ReviewDrug design, development and therapy2023

Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy.

Tomoyuki Tatenuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.